TY - JOUR
T1 - Asymmetric oxidative coupling of hydroxycarbazoles
T2 - Facile synthesis of (+)-bi-2-hydroxy-3-methylcarbazole
AU - Sako, Makoto
AU - Sugizaki, Akimasa
AU - Takizawa, Shinobu
N1 - Funding Information:
The work was supported by JSPS KAKENHI Grant Numbers JP16K08163 (C), JP16H01152 (Middle Molecular Strategy), and JP17H05373 (Coordination Asymmetry). The Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan Society for the Promotion of Science (JSPS), the CREST project of Japan Science and Technology Corporation (JST), and JST Advance Catalytic Transformation Program for Carbon Utilization (ACT-C) Grant Number JPMJCR12YK. We acknowledge the technical staff of the Comprehensive Analysis Center of ISIR, Osaka University (Japan).
Funding Information:
The work was supported by JSPS KAKENHI Grant Numbers JP16K08163 (C), JP16H01152 (Middle Molecular Strategy), and JP17H05373 (Coordination Asymmetry). The Ministry of Education, Culture, Sports, Science and Technology ( MEXT ), Japan Society for the Promotion of Science ( JSPS ), the CREST project of Japan Science and Technology Corporation (JST), and JST Advance Catalytic Transformation Program for Carbon Utilization (ACT-C) Grant Number JPMJCR12YK. We acknowledge the technical staff of the Comprehensive Analysis Center of ISIR, Osaka University (Japan).
Publisher Copyright:
© 2018 Elsevier Ltd
PY - 2018/9/1
Y1 - 2018/9/1
N2 - Asymmetric oxidative coupling reactions of hydroxycarbazoles have been established using a chiral dinuclear vanadium complex. To demonstrate the utility of vanadium-catalyzed reactions, we have used them to synthesize (+)-bi-2-hydroxy-3-carbazole in three steps from cyclohexanone and commercially available aniline derivatives.
AB - Asymmetric oxidative coupling reactions of hydroxycarbazoles have been established using a chiral dinuclear vanadium complex. To demonstrate the utility of vanadium-catalyzed reactions, we have used them to synthesize (+)-bi-2-hydroxy-3-carbazole in three steps from cyclohexanone and commercially available aniline derivatives.
UR - http://www.scopus.com/inward/record.url?scp=85042562637&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85042562637&partnerID=8YFLogxK
U2 - 10.1016/j.bmcl.2018.02.033
DO - 10.1016/j.bmcl.2018.02.033
M3 - Article
C2 - 29503021
AN - SCOPUS:85042562637
SN - 0960-894X
VL - 28
SP - 2751
EP - 2753
JO - Bioorganic and Medicinal Chemistry Letters
JF - Bioorganic and Medicinal Chemistry Letters
IS - 16
ER -